In this work,a novel constitutive model is developed within the framework of fractional plasticity to delineate the coupling between inelastic deformation and damage of quasi-brittle materials.Faced with the common ch...In this work,a novel constitutive model is developed within the framework of fractional plasticity to delineate the coupling between inelastic deformation and damage of quasi-brittle materials.Faced with the common challenge of determining plastic flow direction,we resort herein to the Riemann–Liouville definition of fractional derivatives,instead of introducing an additional plastic potential.The pre-peak hardening behavior is described using an exponential function,while the post-peak softening response is viewed as the consequence of material damage.For describing damage evolution,a damage criterion is constructed in terms of plastic volume dilation related to micro-crack growth.This is conducive to supply a new insight for describing the complex influence of the non-orthogonality of plastic flow on damage evolution.For numerical applications,a semi-implicit return mapping algorithm is proposed.The predictive performance of the model is evaluated by comparing numerical simulations with experimental data under various loading paths.展开更多
BACKGROUND Primary liver cancer is the sixth most common cancer worldwide,with hepato-cellular carcinoma(HCC)being the most prevalent form.Despite the current availability of multiple immune or immune combination trea...BACKGROUND Primary liver cancer is the sixth most common cancer worldwide,with hepato-cellular carcinoma(HCC)being the most prevalent form.Despite the current availability of multiple immune or immune combination treatment options,the prognosis is still poor,so how to identify a more suitable population is extremely important.AIM To evaluate the clinical effectiveness of combining lenvatinib with camrelizumab for patients with hepatitis B virus(HBV)-related HCC in Barcelona Clinic Liver Cancer(BCLC)stages B/C,considering various body mass index(BMI)in diffe-rent categories.METHODS Retrospective data were collected from 126 HCC patients treated with lenvatinib plus camrelizumab.Patients were divided into two groups based on BMI:The non-overweight group(BMI0.05).Subgroup analysis based on BMI showed that obese and overweight patients had better progression-free survival and OS than non-overweight patients,with obese patients showing the best outcomes.Multifactorial regression analysis identified BCLC grade,alpha-fetoprotein level,portal vein tumor thrombosis,and BMI as independent prognostic factors for OS.The column-line graph model highlighted the importance of BMI as a major predictor of patient prognosis,followed by alpha-fetoprotein level,BCLC classification,and portal vein tumor thrombosis.CONCLUSION BMI is a long-term predictor of the efficacy of lenvatinib plus camrelizumab,and obese/overweight patients have a better prognosis.展开更多
Objective: This study investigated complementary feeding practices among four ethnic groups(Han, Uygur, Tibetan, and Zhuang) based on a cross-sectional survey in rural western China. Methods: In 2005, a stratified...Objective: This study investigated complementary feeding practices among four ethnic groups(Han, Uygur, Tibetan, and Zhuang) based on a cross-sectional survey in rural western China. Methods: In 2005, a stratified multistage cluster random sampling method was used to recruit 9712 children(7411 Han, 1032 Uygur, 678 Tibetan, and 591 Zhuang) between 6 and 35 months of age and their mothers from 45 counties in 10 provinces(autonomous regions, municipalities) in western China. Results: The rates of early introduction(before 6 months) of complementary foods in four ethnic groups(Han, Uygur, Tibetan, and Zhuang) were 71.30%, 95.95%, 82.40%, and 72.30%, respectively. The Infant and Child Feeding Index(ICFI) for Uygur and Tibetan children was lower than that for Han children at all age groups. Uygur children were more likely to have unqualified ICFI compared with Han children in a multivariate logistic regression(odds ratio(OR)=5.138, 95% confidence interval(CI): 4.340–6.084). A higher level of maternal education, greater family wealth, and the availability of complementary feeding educational materials decreased the likelihood of an unqualified ICFI. The nutritional status of children(Han, Tibetan, and Zhuang) with qualified ICFI was better than that for children with unqualified ICFI. Conclusions: Appropriate interventions are required to improve complementary feeding practices in rural western China.展开更多
A novel flat-flat resonator consisting of two crystals(Nd:YAG + Nd:YVO4) is established for power scaling in a diode-end-pumped solid-state laser. We systematically compare laser characteristics between multi-seg...A novel flat-flat resonator consisting of two crystals(Nd:YAG + Nd:YVO4) is established for power scaling in a diode-end-pumped solid-state laser. We systematically compare laser characteristics between multi-segmented(Nd:YAG + Nd:YVO4) and conventional composite(Nd:YAG + Nd:YAG) crystals to demonstrate the feasibility of spectral line matching for output power scale-up in end-pumped lasers. A maximum continuous-wave output power of 79.2 W is reported at 1064 nm, with Mx2= 4.82, My2= 5.48, and a pumping power of 136 W in the multi-segmented crystals(Nd:YAG + Nd:YVO4). Compared to conventional composite crystals(Nd:YAG + Nd:YAG), the optical-optical conversion efficiency of multi-segmented crystals(Nd:YAG + Nd:YVO4) from 808 nm to 1064 nm is enhanced from 30% to 58.8%,while the laser output sensitivity as affected by the diode-laser temperature is reduced from 55% to 9%.展开更多
Advanced hepatocellular carcinoma(HCC)is a severe malignancy that poses a serious threat to human health.Owing to challenges in early diagnosis,most patients lose the opportunity for radical treatment when diagnosed.N...Advanced hepatocellular carcinoma(HCC)is a severe malignancy that poses a serious threat to human health.Owing to challenges in early diagnosis,most patients lose the opportunity for radical treatment when diagnosed.Nonetheless,recent advancements in cancer immunotherapy provide new directions for the treatment of HCC.For instance,monoclonal antibodies against immune check-point inhibitors(ICIs)such as programmed cell death protein 1/death ligand-1 inhibitors and cytotoxic t-lymphocyte associated antigen-4 significantly improved the prognosis of patients with HCC.However,tumor cells can evade the immune system through various mechanisms.With the rapid development of genetic engineering and molecular biology,various new immunotherapies have been used to treat HCC,including ICIs,chimeric antigen receptor T cells,engineered cytokines,and certain cancer vaccines.This review summarizes the current status,research progress,and future directions of different immunotherapy strategies in the treatment of HCC.展开更多
基金This work has been jointly supported by the Fundamental Research Funds for the Central Universities(B210203014)the National Key Research and Development Program of China(2017YFC1501100)the National Natural Science Foundation of China(Grant No.11872172).
摘要In this work,a novel constitutive model is developed within the framework of fractional plasticity to delineate the coupling between inelastic deformation and damage of quasi-brittle materials.Faced with the common challenge of determining plastic flow direction,we resort herein to the Riemann–Liouville definition of fractional derivatives,instead of introducing an additional plastic potential.The pre-peak hardening behavior is described using an exponential function,while the post-peak softening response is viewed as the consequence of material damage.For describing damage evolution,a damage criterion is constructed in terms of plastic volume dilation related to micro-crack growth.This is conducive to supply a new insight for describing the complex influence of the non-orthogonality of plastic flow on damage evolution.For numerical applications,a semi-implicit return mapping algorithm is proposed.The predictive performance of the model is evaluated by comparing numerical simulations with experimental data under various loading paths.
摘要BACKGROUND Primary liver cancer is the sixth most common cancer worldwide,with hepato-cellular carcinoma(HCC)being the most prevalent form.Despite the current availability of multiple immune or immune combination treatment options,the prognosis is still poor,so how to identify a more suitable population is extremely important.AIM To evaluate the clinical effectiveness of combining lenvatinib with camrelizumab for patients with hepatitis B virus(HBV)-related HCC in Barcelona Clinic Liver Cancer(BCLC)stages B/C,considering various body mass index(BMI)in diffe-rent categories.METHODS Retrospective data were collected from 126 HCC patients treated with lenvatinib plus camrelizumab.Patients were divided into two groups based on BMI:The non-overweight group(BMI0.05).Subgroup analysis based on BMI showed that obese and overweight patients had better progression-free survival and OS than non-overweight patients,with obese patients showing the best outcomes.Multifactorial regression analysis identified BCLC grade,alpha-fetoprotein level,portal vein tumor thrombosis,and BMI as independent prognostic factors for OS.The column-line graph model highlighted the importance of BMI as a major predictor of patient prognosis,followed by alpha-fetoprotein level,BCLC classification,and portal vein tumor thrombosis.CONCLUSION BMI is a long-term predictor of the efficacy of lenvatinib plus camrelizumab,and obese/overweight patients have a better prognosis.
基金Project supported by the National Natural Science Foundation of China(No.81230016)the Project of Birth Defect Control and Prevention in Shaanxi(No.Sxwsjswzfcght2016-013)+1 种基金the Chinese Ministry of Health(MOH)the United Nations Children’s Fund(UNICEF)(No.YH001)
摘要Objective: This study investigated complementary feeding practices among four ethnic groups(Han, Uygur, Tibetan, and Zhuang) based on a cross-sectional survey in rural western China. Methods: In 2005, a stratified multistage cluster random sampling method was used to recruit 9712 children(7411 Han, 1032 Uygur, 678 Tibetan, and 591 Zhuang) between 6 and 35 months of age and their mothers from 45 counties in 10 provinces(autonomous regions, municipalities) in western China. Results: The rates of early introduction(before 6 months) of complementary foods in four ethnic groups(Han, Uygur, Tibetan, and Zhuang) were 71.30%, 95.95%, 82.40%, and 72.30%, respectively. The Infant and Child Feeding Index(ICFI) for Uygur and Tibetan children was lower than that for Han children at all age groups. Uygur children were more likely to have unqualified ICFI compared with Han children in a multivariate logistic regression(odds ratio(OR)=5.138, 95% confidence interval(CI): 4.340–6.084). A higher level of maternal education, greater family wealth, and the availability of complementary feeding educational materials decreased the likelihood of an unqualified ICFI. The nutritional status of children(Han, Tibetan, and Zhuang) with qualified ICFI was better than that for children with unqualified ICFI. Conclusions: Appropriate interventions are required to improve complementary feeding practices in rural western China.
基金Project supported by the National Defense Pre-Research Foundation of China(Grant No.9140A020105)
摘要A novel flat-flat resonator consisting of two crystals(Nd:YAG + Nd:YVO4) is established for power scaling in a diode-end-pumped solid-state laser. We systematically compare laser characteristics between multi-segmented(Nd:YAG + Nd:YVO4) and conventional composite(Nd:YAG + Nd:YAG) crystals to demonstrate the feasibility of spectral line matching for output power scale-up in end-pumped lasers. A maximum continuous-wave output power of 79.2 W is reported at 1064 nm, with Mx2= 4.82, My2= 5.48, and a pumping power of 136 W in the multi-segmented crystals(Nd:YAG + Nd:YVO4). Compared to conventional composite crystals(Nd:YAG + Nd:YAG), the optical-optical conversion efficiency of multi-segmented crystals(Nd:YAG + Nd:YVO4) from 808 nm to 1064 nm is enhanced from 30% to 58.8%,while the laser output sensitivity as affected by the diode-laser temperature is reduced from 55% to 9%.
摘要Advanced hepatocellular carcinoma(HCC)is a severe malignancy that poses a serious threat to human health.Owing to challenges in early diagnosis,most patients lose the opportunity for radical treatment when diagnosed.Nonetheless,recent advancements in cancer immunotherapy provide new directions for the treatment of HCC.For instance,monoclonal antibodies against immune check-point inhibitors(ICIs)such as programmed cell death protein 1/death ligand-1 inhibitors and cytotoxic t-lymphocyte associated antigen-4 significantly improved the prognosis of patients with HCC.However,tumor cells can evade the immune system through various mechanisms.With the rapid development of genetic engineering and molecular biology,various new immunotherapies have been used to treat HCC,including ICIs,chimeric antigen receptor T cells,engineered cytokines,and certain cancer vaccines.This review summarizes the current status,research progress,and future directions of different immunotherapy strategies in the treatment of HCC.
基金funded by the National Science and Technology Major Project,China(Nos.2017VI-0002-0072,2019-VI-0020-0135)the National Natural Science Foundation of China(Nos.51771148,52071263)+4 种基金the Key Research and Development Program of Shaanxi Province,China(No.2020ZDLGY13-02)the Natural Science Basic Research Plan in Shaanxi Province,China(No.2021JC-13)the Research Fund of the State Key Laboratory of Solidification Processing(NPU),China(No.2021-QZ-03)the Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University,China(No.CX2021057)the Science,Technology,and Innovation Commission of Shenzhen Municipality,China(No.JCYJ20180306171121424)。